Evidence map›Paper›PMID 38589783›Full record

ArticleBMC medical research methodology2024

Spatial-temporal Bayesian accelerated failure time models for survival endpoints with applications to prostate cancer registry data.

Ming Wang, Zheng Li, Jun Lu, Lijun Zhang, Yimei Li, Liangliang Zhang

Open access · goldAbstract read
In one paragraph

Article in BMC medical research methodology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Ming WangDepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. mxw827@case.edu.
Zheng LiNovartis Pharmaceuticals, East Hanover, NJ, USA.
Jun LuDivision of Epidemiology and Biostatistics, School of Public Health, University of Illinois Chicago, Chicago, IL, USA.
Lijun ZhangDepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
Yimei LiDepartment of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
Liangliang ZhangDepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
Case Western Reserve University · USNovartis (United States) · USUniversity of Illinois Chicago · USUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer is the most common cancer after non-melanoma skin cancer and the second leading cause of cancer deaths in US men. Its incidence and mortality rates vary substantially across geographical regions and over time, with large disparities by race, geographic regions (i.e., Appalachia), among others. The widely used Cox proportional hazards model is usually not applicable in such scenarios owing to the violation of the proportional hazards assumption. In this paper, we fit Bayesian accelerated failure time models for the analysis of prostate cancer survival and take dependent spatial structures and temporal information into account by incorporating random effects with multivariate conditional autoregressive priors. In particular, we relax the proportional hazards assumption, consider flexible frailty structures in space and time, and also explore strategies for handling the temporal variable. The parameter estimation and inference are based on a Monte Carlo Markov chain technique under a Bayesian framework. The deviance information criterion is used to check goodness of fit and to select the best candidate model. Extensive simulations are performed to examine and compare the performances of models in different contexts. Finally, we illustrate our approach by using the 2004-2014 Pennsylvania Prostate Cancer Registry data to explore spatial-temporal heterogeneity in overall survival and identify significant risk factors.

Indexed as

Models, StatisticalProstatic NeoplasmsBayes TheoremHumansMaleMarkov ChainsProportional Hazards ModelsRoutinely Collected Health DataAccelerated failure timesBayesian inferenceMonte Carlo Markov chainMultivariate conditional autoregressive priorsProstate cancerSpatial-temporal modeling

Identifiers

PMID38589783
PMCPMC11003030
OpenAlexW4394569933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.